RT @DrPetryna: Abst1810 #acr21 @RheumNow survey of pt preferred meds for PsA points out â¬ï¸ interest in IL17 & PD
Tweet Content
Abst1810 #acr21 @RheumNow survey of pt preferred meds for PsA points out ⬆️ interest in IL17 & PDE4 since 2018 guideline update: anti-IL17 compared to 2018 or earlier (30% vs 3.5% p< 0.001);anti-PDE4 (40% vs 11.5% p< 0.012). Meds SEs& prevention of joint damage important for pts
Show on Archive Page
On
Display in Search Results
On
PDQ
Off